Julie J. Ruterbusch

ORCID: 0000-0001-8089-7409
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Global Cancer Incidence and Screening
  • Endometrial and Cervical Cancer Treatments
  • Cancer Risks and Factors
  • Breast Cancer Treatment Studies
  • Prostate Cancer Treatment and Research
  • Multiple and Secondary Primary Cancers
  • Cancer survivorship and care
  • Breast Lesions and Carcinomas
  • Prostate Cancer Diagnosis and Treatment
  • Renal cell carcinoma treatment
  • Childhood Cancer Survivors' Quality of Life
  • Family Support in Illness
  • Cancer, Lipids, and Metabolism
  • Ovarian cancer diagnosis and treatment
  • Renal and related cancers
  • Economic and Financial Impacts of Cancer
  • Palliative Care and End-of-Life Issues
  • Molecular Biology Techniques and Applications
  • BRCA gene mutations in cancer
  • Head and Neck Cancer Studies
  • Cancer-related molecular mechanisms research
  • Migration, Health and Trauma
  • Air Quality and Health Impacts
  • Food Security and Health in Diverse Populations
  • Acute Lymphoblastic Leukemia research

The Barbara Ann Karmanos Cancer Institute
2016-2025

Wayne State University
2016-2025

Northwestern University
2023

Huntsman Cancer Institute
2019

University of Utah
2019

Michigan United
2018

Michigan State University
2017

Woodward (United States)
2017

United States Department of Health and Human Services
2016

National Cancer Institute
2012-2016

The incidence of prostate cancer is approximately 60% higher and the mortality rate 2 to 3 times greater in black than white American men. We propose that a more rapid growth and/or earlier transformation from latent aggressive men contribute this disparity.We evaluated entirely embedded glands on autopsy 1,056 who died causes other cancer. also reviewed data our radical prostatectomy database Detroit Surveillance, Epidemiology End Results database.Autopsy indicated subclinical starts at...

10.1016/j.juro.2010.01.015 article EN The Journal of Urology 2010-03-18

Inflammatory breast cancer (IBC) is characterized by an apparent geographical distribution in incidence, being more common North Africa than other parts of the world. Despite rapid growth immigrants to United States from Arab nations, little known about disease patterns among Americans because a racial category rarely considered for this group. The aim study was advance our understanding burden IBC ethnic populations describing proportion different groups, including Detroit, New Jersey and...

10.1186/2193-1801-2-3 article EN SpringerPlus 2013-01-07

In contrast with the decreasing incidence seen for most cancers, endometrial cancer has been increasing in United States. We examined whether and mortality from are equally distributed by race/ethnicity tumor histologic subtype.Surveillance, Epidemiology, End Results (SEER) data were obtained 2000 to 2011. Age-adjusted incidence-based rates, 95% confidence intervals, annual percent changes (APC) calculated. Rate ratios calculated compare racial/ethnic groups. Five-year relative survival...

10.1158/1055-9965.epi-15-0316 article EN Cancer Epidemiology Biomarkers & Prevention 2015-08-20

Despite more aggressive screening across all demographics and gradual declines in mortality related to prostate cancer (PCa) the United States, disparities among populations persist. A substantial proportion of African American men (AAM) have a higher overall incidence, earlier age onset, increased clinically advanced disease, bone metastases from PCa compared European (EAM). Limited early evidence indicates that underlying causes for may be observed tumor-specific gene expression...

10.1158/1055-9965.epi-12-1238 article EN Cancer Epidemiology Biomarkers & Prevention 2013-03-21

Background: Renal cell carcinoma and hypertension (a well-established renal cancer risk factor) are both more frequent among blacks than whites in the United States. The association between has not been examined black Americans. We investigated hypertension–renal by race, we assessed role of racial disparity incidence. Methods: Participants were enrolled a population-based case-control study Detroit Chicago during 2002–2007 (number cases: 843 whites, 358 blacks; number controls: 707 519...

10.1097/ede.0b013e3182300720 article EN Epidemiology 2011-10-04

Racial disparities in colorectal cancer (CRC) persist, despite overall reductions morbidity and mortality. In addition, incidence is rising among individuals younger than 50 years of age. We compared the survival young-onset CRC non-Hispanic black (NHB), white (NHW), Hispanic individuals.Using National Cancer Institute's Surveillance, Epidemiology, End Results program data, we identified between ages 20 49 years, diagnosed with 2000 2009. Survival rates Cox proportional hazards models were...

10.1200/jco.2015.65.0994 article EN Journal of Clinical Oncology 2016-05-03

Background: Incidence and survival rates of nonserous epithelial ovarian cancer in racial/ethnic minorities remain relatively unknown the United States. We examined trends incidence for by histologic subtypes race/ethnicity.Methods: Ovarian mortality data from 2000 to 2013 were obtained Surveillance, Epidemiology, End Results database. Age-adjusted rate, rate ratio, annual percentage changes (APC) calculated histology race/ethnicity subgroups stratified age at diagnosis. Five-year relative...

10.1158/1055-9965.epi-17-0290 article EN Cancer Epidemiology Biomarkers & Prevention 2017-07-28

Cardiometabolic abnormalities are a leading cause of death among women, including women with cancer. This study examined the association between prediagnosis cardiovascular health and total cause-specific mortality 12,076 postmenopausal who developed local- or regional-stage invasive cancer in Women's Health Initiative (WHI). Cardiovascular risk factors included waist circumference, hypertension, high cholesterol, type 2 diabetes. Obesity-related cancers breast cancer, colorectal endometrial...

10.1002/cncr.33295 article EN Cancer 2020-11-05

No AccessJournal of UrologyAdult Urology1 Dec 2010Contemporary Clinical Epidemiology Renal Cell Carcinoma: Insight From a Population Based Case-Control Study David C. Miller, Julie Ruterbusch, Joanne S. Colt, Faith G. Davis, W. Marston Linehan, Wong-Ho Chow, and Kendra Schwartz MillerDavid Miller Department Urology, University Michigan Veterans Affairs Center for Management Research, Ann Arbor, , RuterbuschJulie Ruterbusch Karmanos Cancer Institute, Wayne State School Medicine, Detroit,...

10.1016/j.juro.2010.08.018 article EN The Journal of Urology 2010-10-17

To investigate whether renal cell carcinoma (RCC) histologic subtypes possess different etiologies, we conducted analyses of established RCC risk factors by subtype (clear cell, papillary and chromophobe) in two case-control studies the United States (1,217 cases, 1,235 controls) Europe (1,097 1,476 controls). Histology was ascertained for 706 U.S. cases (58% total) 917 European (84%) through a central slide review single pathologist. For remaining histology abstracted from original...

10.1002/ijc.27934 article EN International Journal of Cancer 2012-11-14

Objective The incidence of renal cell carcinoma (RCC) has increased rapidly in the U.S., particularly among African Americans. Despite a well‐established link between obesity and RCC, mechanism through which increases cancer risk yet to be established. Adipokines, such as leptin adiponectin, may cancer, with different quantitative effects by race. Design Methods We evaluated association adiponectin concentrations RCC Caucasians (581 cases, 558 controls) Americans (187 359 case‐control study...

10.1002/oby.20138 article EN Obesity 2013-05-13

There is continuing controversy about prostate cancer testing and the recent American Urological Association guidelines. We hypothesize that reduction elimination of racial survival disparity among African men (AAM; high-risk group) compared with European (EAM; intermediate-risk during PSA era pre-PSA strongly supports use in AAM.

10.1158/1055-9965.epi-13-1328 article EN Cancer Epidemiology Biomarkers & Prevention 2014-05-07

Background The incidence of nasopharyngeal carcinoma (NPC) has been historically low in the United States. Although etiological factors differ by histological subtype, Epstein‐Barr virus is accepted as primary risk factor for nonkeratinizing NPC. In light changing epidemiology viral‐associated cancers, it important to evaluate temporal NPC Methods Incidence and survival data from 1973 through 2015 were obtained Surveillance, Epidemiology, End Results program. Stratified analyses conducted...

10.1002/cncr.32517 article EN Cancer 2019-09-16

Background The benefit of regular exercise in improving cancer outcomes is well established. American Cancer Society (ACS) released a recommendation that survivors should engage at least 150 minutes moderate to vigorous physical activity (PA) per week; however, few report meeting this recommendation. This study examined the patterns and correlates ACS PA recommendations Detroit Research on Survivors (ROCS) cohort African survivors. Methods ROCS participants completed baseline yearly...

10.1002/cncr.32725 article EN Cancer 2020-02-24

Abstract Background: Racial segregation is linked to poorer neighborhood quality and adverse health conditions among minorities, including worse cancer outcomes. We evaluated relationships between race, social disadvantage, survival. Methods: calculated overall cancer-specific survival for 11,367 non-Hispanic Black (NHB) 29,481 White (NHW) individuals with breast, colorectal, lung, or prostate using data from the Metropolitan Detroit Cancer Surveillance System. The area deprivation index...

10.1158/1055-9965.epi-22-0738 article EN Cancer Epidemiology Biomarkers & Prevention 2023-01-11

Abstract Background Immune checkpoint inhibitors have profoundly impacted survival among patients with metastatic non–small cell lung cancer. However, population-based studies evaluating this impact on by race and socioeconomic factors are lacking. Methods We used the Surveillance, Epidemiology, End Results Program–Medicare database to identify cancer diagnosed between 2015 2019. The primary study outcomes were receipt of an immune inhibitor overall survival. χ2 tests logistic regression...

10.1093/jnci/djae118 article EN cc-by JNCI Journal of the National Cancer Institute 2024-06-03

ABSTRACT Background There has been a lack of updated epidemiological data on the incidence and survival outcomes for patients with small cell lung cancer (SCLC) in United States over last two decades. Methods A retrospective, population‐based study was conducted utilizing Surveillance, Epidemiology, End Results (SEER) program to identify SCLC from 2000 2020. Trends incidence, incidence‐based mortality rates, 1‐year relative rates observed were evaluated SEER database. The database identified...

10.1002/cam4.70608 article EN cc-by Cancer Medicine 2025-02-01

The aim of this study was to estimate and compare the age-specific sex-adjusted case-fatality rates (CFRs) among Arab Americans Hispanic, non-Hispanic Black, White, Asian adults living in Michigan. Data from Michigan’s vital records, surveillance data (March 2020-July 2021), an Arab/Chaldean surname algorithm were used. We used χ2 tests determine statistically significant differences between groups. Logistic regression CFRs. had a lower CFR 1.54% compared with (1.97%), White (2.17%), Black...

10.18865/ethndis-2023-82 article EN Ethnicity & Disease 2025-03-01

Abstract Background: Black women with endometrial cancer (EC) have twice the mortality compared to White. Survival disparities remain after accounting for individual-level socioeconomic and cancer-related factors. We investigated associations between area-based deprivation survival explored whether attenuates association race survival, among a cohort of White women. Methods: Data from ECs diagnosed 2013-2022 were collected comprehensive registry covering Metropolitan Detroit. Addresses at...

10.1158/1055-9965.epi-24-1833 article EN Cancer Epidemiology Biomarkers & Prevention 2025-03-21
Coming Soon ...